Cell/Gene Tx channel feed – Endpoints News

Cell/Gene Tx channel feed

Fibrocell Science sees light at the end of the tunnel with Castle Creek deal to develop 'butterfly' disease gene therapy

7 years ago

Ahead of US gene therapy explosion, big contract drug manufacturer Catalent makes $1.2 billion bet on Paragon Bioservices

7 years ago

Two Syncona-backed players join forces to take on retinal gene therapies

7 years ago

Jude Samulski's gene therapy company just raised $235M for clinical development

7 years ago

Gene therapies for the cats and dogs you love? Penn-partnered Scout Bio just raised $20M to make it a reality

7 years ago

Another player in the gene therapy field is gunning for the Duchenne MD crown — and here’s what they're betting on

7 years ago

To be cost-effective, Biogen should slash Spinraza price, and Novartis cannot justify a $4M-$5M price tag for Zolgensma — ICER

7 years ago

Takeda takes a cautious step into neurological gene therapy, inking preclinical deal with StrideBio

7 years ago

Bluebird's one-shot gene therapy for beta thalassemia officially secures EMA backing — approval expected in the second quarter

7 years ago

Pfizer lines up a potential $687M rare disease buyout to expand its stake in the hot gene therapy field

7 years ago

Early data snapshots of Axovant's gene therapies for Parkinson's, Tay Sachs appear promising

7 years ago

Appetite for gene therapies gains momentum, as Biogen plans $800M buyout of Nightstar Therapeutics

7 years ago

Sarepta posts early, rosy gene therapy data for limb girdle muscular dystrophy — fueling $165M buyout of partner

7 years ago

Cornell researchers to launch early trial of gene therapy aimed — ultimately — at preventing Alzheimer's

7 years ago

By the numbers: Top M&A deals, VC investments and pacts point to a growing hunger for gene therapy deals

7 years ago

Roche joins the M&A game, buying gene therapy pioneer Spark for $4.3B

7 years ago

Stem cell therapies for space missions? Pluristem joins forces with NASA to combat space-related ailments

7 years ago

Encouraging gene therapy data give uniQure an injection of confidence as it preps PhIII showdown with Spark

7 years ago

Solid Bio is hit by another setback as initial biopsies spotlight a flop for Duchenne MD

7 years ago

Avrobio takes a second stab at a good first impression — but durability questions still dog gene therapy

7 years ago

J&J snags rights to a gene therapy portfolio from little MeiraGTx, a spinoff from Sam Waksal’s Kadmon

7 years ago

Voyager bags a 'transformational' $1.8B gene therapy pact with Neurocrine

7 years ago

A stem cell therapy preps debut in Japanese market to the dismay of US researchers

7 years ago

Gottlieb, Marks detail plans to advance development of cell and gene therapies

7 years ago

First page Previous page 52 53 545556 57 58 Next page Last page